Muco-regulating
drugs are cysteine derivatives
whose thiol group is not free.
They are headed by Carbocysteine
(which activates the synthesis of
sialized acid mucins).
They enable reorganization of bronchial
mucus secretion, improve the muco
ciliary transportation of bronchial
mucus, they have complementary anti-inflammatory
action.
Mucosol...
Is unlike traditional mucolytics,
it has a protected thiol group.
Regulates bronchial mucus.
Restores normal ciliary function.
Normalizes and smoothens expectoration.
Decreases cough frequency.
Does not increase of sputum volume.
Decreases liability for chest infections
Improves Respiratory Functions.
Lack of gastric effects.
Covers wide range of respiratory
disorders.
Has high safety profile.
Provides synergistic effect when
combined with antibiotics in respiratory
tract infections.
Improves the bronchial kinetics
of antibiotics.
Allows easier penetration of antibiotics
into pathological secretions.
Increases antibiotic level in the
bronchial mucus.
Eradicates completely the causative
pathogens in combination with antibiotics.
Results in satisfactory clinical
recovery in a short time.
Prevents relapses of respiratory
tract infections.
